These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1051 related items for PubMed ID: 15870945

  • 1. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O, Junicho A, Akashi T, Koizumi K, Matsuda T, Fuse H, Saiki I.
    Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
    [Abstract] [Full Text] [Related]

  • 2. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R.
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [Abstract] [Full Text] [Related]

  • 3. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.
    García-Fernández MO, Collado B, Bodega G, Cortés J, Ruíz-Villaespesa A, Carmena MJ, Prieto JC.
    Gynecol Endocrinol; 2005 Jun; 20(6):327-33. PubMed ID: 16019382
    [Abstract] [Full Text] [Related]

  • 4. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L, Ahrén B, Edgren G, Degerman E.
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [Abstract] [Full Text] [Related]

  • 5. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G, Malendowicz LK, Neri G, Andreis PG, Ziolkowska A, Gottardo L, Nowak KW, Nussdorfer GG.
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [Abstract] [Full Text] [Related]

  • 6. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Feb 01; 162(3):1707-16. PubMed ID: 9973433
    [Abstract] [Full Text] [Related]

  • 7. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H.
    Endocrinology; 1999 Mar 01; 140(3):1285-93. PubMed ID: 10067855
    [Abstract] [Full Text] [Related]

  • 8. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y, Xin X, Shim GJ, Mokuno Y, Uehara H, Yamada T, Agui T, Matsumoto K.
    Endocrinology; 1997 Jun 01; 138(6):2515-20. PubMed ID: 9165043
    [Abstract] [Full Text] [Related]

  • 9. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC, Läderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA.
    Cancer Res; 2000 Jun 01; 60(11):3105-12. PubMed ID: 10850463
    [Abstract] [Full Text] [Related]

  • 10. Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP.
    Zusev M, Gozes I.
    Regul Pept; 2004 Dec 15; 123(1-3):33-41. PubMed ID: 15518891
    [Abstract] [Full Text] [Related]

  • 11. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development.
    Basille M, Vaudry D, Coulouarn Y, Jegou S, Lihrmann I, Fournier A, Vaudry H, Gonzalez B.
    J Comp Neurol; 2000 Oct 02; 425(4):495-509. PubMed ID: 10975876
    [Abstract] [Full Text] [Related]

  • 12. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S, Latini S, Barberi M, Teti A, Stefanini M, Canipari R.
    J Endocrinol; 2006 Oct 02; 191(1):287-99. PubMed ID: 17065411
    [Abstract] [Full Text] [Related]

  • 13. Expression of mRNAs for PACAP and its receptor in human neuroblastomas and their relationship to catecholamine synthesis.
    Isobe K, Kaneko M, Kaneko S, Nissato S, Nanmoku T, Takekoshi K, Okuda Y, Kawakami Y.
    Regul Pept; 2004 Dec 15; 123(1-3):29-32. PubMed ID: 15518890
    [Abstract] [Full Text] [Related]

  • 14. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
    Schulz S, Röcken C, Mawrin C, Weise W, Höllt V, Schulz S.
    Clin Cancer Res; 2004 Dec 15; 10(24):8235-42. PubMed ID: 15623599
    [Abstract] [Full Text] [Related]

  • 15. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Apr 15; 162(8):4685-96. PubMed ID: 10202009
    [Abstract] [Full Text] [Related]

  • 16. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC.
    Endocrinology; 1996 Jul 15; 137(7):2815-22. PubMed ID: 8770902
    [Abstract] [Full Text] [Related]

  • 17. Activation of VPAC1 receptors by VIP and PACAP-27 in human bronchial epithelial cells induces CFTR-dependent chloride secretion.
    Dérand R, Montoni A, Bulteau-Pignoux L, Janet T, Moreau B, Muller JM, Becq F.
    Br J Pharmacol; 2004 Feb 15; 141(4):698-708. PubMed ID: 14744818
    [Abstract] [Full Text] [Related]

  • 18. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
    Nagata A, Tanaka T, Minezawa A, Poyurovsky M, Mayama T, Suzuki S, Hashimoto N, Yoshida T, Suyama K, Miyata A, Hosokawa H, Nakayama T, Tatsuno I.
    J Cell Physiol; 2009 Oct 15; 221(1):75-83. PubMed ID: 19496170
    [Abstract] [Full Text] [Related]

  • 19. Long-acting analogue of vasoactive intestinal peptide, [R15, 20, 21, L17]-VIP-GRR (IK312532), protects rat alveolar L2 cells from the cytotoxicity of cigarette smoke.
    Onoue S, Endo K, Ohmori Y, Yamada S, Kimura R, Yajima T, Kashimoto K.
    Regul Pept; 2004 Dec 15; 123(1-3):193-9. PubMed ID: 15518912
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of mRNAs for PACAP and its receptors during neural differentiation of embryonic stem cells.
    Hirose M, Hashimoto H, Shintani N, Nakanishi M, Arakawa N, Iga J, Niwa H, Miyazaki J, Baba A.
    Regul Pept; 2005 Mar 15; 126(1-2):109-13. PubMed ID: 15620423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.